Effects of Travatan Z and Xalatan on Ocular Surface Health

PHASE4CompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)

Ophthalmic solution for the treatment of open-angle glaucoma or ocular hypertension, one drop a day, dosed topically for 12 weeks (84 days). Referred to as travoprost.

DRUG

Latanoprost ophthalmic solution 0.005% (XALATAN®)

Ophthalmic solution for the treatment of open-angle glaucoma or ocular hypertension, one drop a day, dosed topically for 12 weeks (84 days). Referred to as latanoprost.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00708422 - Effects of Travatan Z and Xalatan on Ocular Surface Health | Biotech Hunter | Biotech Hunter